Kristen Krysko * UCSF Profiles

Kristen Krysko, MD

Title(s)	Clinical Fellow, Neurology
School	School of Medicine
Phone	415-353-2069
vCard	Download vCard

Other Positions


Title(s)	UCSF Weill Institute for Neurosciences

Biography

Education and Training

University of Toronto, Toronto, ON, Canada	FRCPC	06/2017	Neurology Residency
University of Toronto, Toronto, ON, Canada	MD	06/2012	Medicine
McMaster University, Hamilton, ON, Canada	BSc	06/2008	Biology and Psychology

Overview

I started as a Multiple Sclerosis Clinical Research Fellow at UCSF in July 2017, after completing residency in Neurology at the University of Toronto in June 2017. I have a strong interest in clinical research related to multiple sclerosis, and my research mentors at UCSF include Dr. Waubant and Dr. Graves. My research interests include identifying modifiable risk factors for MS and interventions targeted at these, clinical trials of disease modifying therapies (DMTs), the impact of pregnancy on those with MS and MS management during pregnancy, and pediatric onset MS. Other areas of interest include studying treatment of fatigue in MS.

Interests

Multiple sclerosis, Pediatric MS, Pregnancy and MS, Disease modifying therapies, Women's health in MS

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Krysko KM, Henry RG, Cree BAC, Lin J. Telomere length is associated with disability progression in multiple sclerosis. Ann Neurol. 2019 Sep 04. PMID: 31486104.

View in: PubMed
Manguinao M, Krysko KM, Maddike S, Rutatangwa A, Francisco C, Hart J, Chong J, Graves JS, Waubant E. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. Mult Scler Relat Disord. 2019 Jul 08; 35:50-54. PMID: 31319355.

View in: PubMed
Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787. PMID: 30333163.

View in: PubMed
Rotstein DL, Chen H, Wilton AS, Kwong JC, Marrie RA, Gozdyra P, Krysko KM, Kopp A, Copes R, Tu K. Temporal trends in multiple sclerosis prevalence and incidence in a large population. Neurology. 2018 04 17; 90(16):e1435-e1441. PMID: 29549225.

View in: PubMed
Krysko KM, Sundaram AN. Recurrent Alternate-Sided Homonymous Hemianopia Due to Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report. Neuroophthalmology. 2017 Feb; 41(1):30-34. PMID: 28228835.

View in: PubMed
Krysko KM, O'Connor P. Quality of Life, Cognition and Mood in Adults with Pediatric Multiple Sclerosis. Can J Neurol Sci. 2016 May; 43(3):368-74. PMID: 26795374.

View in: PubMed
Krysko KM, Ivers NM, Young J, O'Connor P, Tu K. Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler. 2015 Feb; 21(2):217-24. PMID: 24948683.

View in: PubMed
Krysko KM, O'Connor PW. The toronto observational study of natalizumab in multiple sclerosis. Can J Neurol Sci. 2011 May; 38(3):422-8. PMID: 21515500.

View in: PubMed
Krysko KM, Rutherford MD. A threat-detection advantage in those with autism spectrum disorders. Brain Cogn. 2009 Apr; 69(3):472-80. PMID: 19036491.

View in: PubMed
Rutherford MD, Krysko KM. Eye direction, not movement direction, predicts attention shifts in those with autism spectrum disorders. J Autism Dev Disord. 2008 Nov; 38(10):1958-65. PMID: 18521729.

View in: PubMed
Rutherford MD, Chattha HM, Krysko KM. The use of aftereffects in the study of relationships among emotion categories. J Exp Psychol Hum Percept Perform. 2008 Feb; 34(1):27-40. PMID: 18248138.

View in: PubMed